Skip to main content
Premium Trial:

Request an Annual Quote

Scimagix Moves into Europe; New MRC Spin-off Hires Orchid s Ashton as CEO

NEW YORK, Nov. 20-Scimagix said yesterday that it had expanded its European operations and added a new vice president of marketing, John Andrews.


The San Mateo, Calif.-based bioinformatics firm has opened new headquarters in Luton, England and sales and support offices in Munich, Germany and Paris, France in response to "growing demand" for its products in Europe, the company said.


Andrews will manage expansion in these new markets. He was previously executive vice president of field operations for Aurigin Systems, a patent information company. Prior to that, he was executive vice president of sales and marketing for Entelos.


The company also hired Bob Marchmont as Business Area Director for Proteomics. Marchmont, who was previously with Nonlinear Dynamics, will lead product marketing efforts for the company's ProteinMine line.



Psychiatric Genomics said yesterday that it had added Michael Knable to its scientific advisory board. Knable is medical director for the Stanley Medical Research Institute, which funds and conducts research on schizophrenia and bipolar disorder. Psychiatric Genomics has a research collaboration with the SMRI, and the institute also has invested in the company.




Chris Ashton has been appointed chief executive officer of the new British knockout mouse company Etiologics, the firm announced on Nov. 18.


Ashton, 42, was previously Vice President and Managing Director of European Operations at Orchid Biosciences, where he established and managed the company's European division. During this time, Ashton arranged the company's first major SNP genotyping deal and directed the acquisition of Cellmark Diagnostics from AstraZeneca.


Before joining Orchid in 2000, he was commercial director of Inpharmatica, the University College London bioinformatics spin-off.


Etiologics, based in Oxford, UK, develops and screens new knockout mice for use as disease models in drug discovery. It was spun out last month from the Medical Research Council Mammalian Genetics Unit.



Promoted? Changing jobs? GenomeWeb wants to know. E-mail Kathleen McGowan at [email protected] to appear in PEOPLE, a roundup of personnel comings and goings in genomics, that appears every Wednesday.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.